212 related articles for article (PubMed ID: 8862935)
1. Treatment of adenoviral conjunctivitis with topical cidofovir.
Gordon YJ; Naesens L; DeClercq E; Maudgal PC; Veckeneer M
Cornea; 1996 Sep; 15(5):546. PubMed ID: 8862935
[No Abstract] [Full Text] [Related]
2. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
[TBL] [Abstract][Full Text] [Related]
4. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
Romanowski EG; Araullo-Cruz T; Gordon YJ
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
[TBL] [Abstract][Full Text] [Related]
5. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
Romanowski EG; Gordon YJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861
[TBL] [Abstract][Full Text] [Related]
6. Recurrent iritis after intravenous administration of cidofovir.
Palau LA; Tufty GT; Pankey GA
Clin Infect Dis; 1997 Aug; 25(2):337-8. PubMed ID: 9332544
[No Abstract] [Full Text] [Related]
7. [Prospects for therapy and prevention of adenovirus keratoconjunctivitis].
Sundmacher R; Hillenkamp J; Reinhard T
Ophthalmologe; 2001 Oct; 98(10):991-1007; quiz 1008-9. PubMed ID: 11699326
[No Abstract] [Full Text] [Related]
8. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model.
Romanowski EG; Yates KA; Gordon YJ
Antiviral Res; 2001 Dec; 52(3):275-80. PubMed ID: 11675144
[TBL] [Abstract][Full Text] [Related]
9. Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis.
Friedberg DN
Arch Ophthalmol; 1997 Jun; 115(6):801-2. PubMed ID: 9194736
[No Abstract] [Full Text] [Related]
10. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.
Ribaud P; Scieux C; Freymuth F; Morinet F; Gluckman E
Clin Infect Dis; 1999 Mar; 28(3):690-1. PubMed ID: 10194105
[No Abstract] [Full Text] [Related]
11. Intravenous cidofovir-induced iritis.
Neau D; Renaud-Rougier MB; Viallard JE; Dutronc H; Cazorla C; Ragnaud JM; Dupon M; Lacut JY
Clin Infect Dis; 1999 Jan; 28(1):156-7. PubMed ID: 10028099
[No Abstract] [Full Text] [Related]
12. The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
Kaneko H; Mori S; Suzuki O; Iida T; Shigeta S; Abe M; Ohno S; Aoki K; Suzutani T
Antiviral Res; 2004 Jan; 61(1):63-6. PubMed ID: 14670595
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir approved.
PI Perspect; 1996 Sep; (No 19):14-5. PubMed ID: 11363898
[TBL] [Abstract][Full Text] [Related]
14. Treatment of verruca vulgaris with topical cidofovir.
Zabawski EJ; Sands B; Goetz D; Naylor M; Cockerell CJ
JAMA; 1997 Oct; 278(15):1236. PubMed ID: 9333263
[No Abstract] [Full Text] [Related]
15. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.
Toro JR; Wood LV; Patel NK; Turner ML
Arch Dermatol; 2000 Aug; 136(8):983-5. PubMed ID: 10926733
[No Abstract] [Full Text] [Related]
16. Gilead issues new warnings about cidofovir nephrotoxicity.
Am J Health Syst Pharm; 1997 Jan; 54(1):12, 15. PubMed ID: 9117780
[No Abstract] [Full Text] [Related]
17. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Ljungman P; Ribaud P; Eyrich M; Matthes-Martin S; Einsele H; Bleakley M; Machaczka M; Bierings M; Bosi A; Gratecos N; Cordonnier C;
Bone Marrow Transplant; 2003 Mar; 31(6):481-6. PubMed ID: 12665844
[TBL] [Abstract][Full Text] [Related]
18. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
[No Abstract] [Full Text] [Related]
19. Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis.
Lalezari JP; Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S27-31. PubMed ID: 9058615
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Soltau JB
Ocul Immunol Inflamm; 2001 Sep; 9(3):137-9. PubMed ID: 11815882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
